<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1939900/" ref="ordinalpos=1446&amp;ncbi_uid=1016421&amp;link_uid=PMC1939900" image-link="/pmc/articles/PMC1939900/figure/F6/" class="imagepopup">Figure 6.  From: Regulation of COX-2-mediated <span class="highlight" style="background-color:">signaling</span> by ?3 type IV noncollagenous domain in tumor angiogenesis. </a></div><br /><div class="p4l_captionBody"><b>Schematic illustration of different signaling pathway mediated by α3(IV)NC1.</b> α3(IV)NC1 binds to αVβ3 and α3β1 integrins and inhibit phosphorylation of FAK. Inhibition of FAK activation leads to inhibition of FAK/phosphatidylinositol 3-kinase/eIF4E/4E-BP1. In addition, α3(IV)NC1 also inhibits NFκB-mediated signaling in hypoxic conditions leads to inhibition of COX-2/VEGF/bFGF expressions, resulting in inhibition of hypoxic tumor angiogenesis.</div></div>